Risk of infections during interferon‐based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|6|1057-1064

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.6, 2015-06, pp. : 1057-1064

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Viral Kinetics during Treatment of Chronic Hepatitis C Virus Infection with Pegylated Interferon Alpha plus Ribavirin in Taiwan

By  

Intervirology, Vol. 50, Iss. 4, 2007-07 ,pp. : 310-315

Karger

Access to resources Recommend Favorite

Artificial Neural Network Model Is Superior to Logistic Regression Model in Predicting Treatment Outcomes of Interferon-Based Combination Therapy in Patients with Chronic Hepatitis C

By  

Intervirology, Vol. 51, Iss. 1, 2008-02 ,pp. : 14-20

Karger

Access to resources Recommend Favorite

Long-Term Effects of Interferon-Based Therapy for Chronic Hepatitis C

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon‐based therapy: FUNDAMENTAL, a Phase II trial

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 7, 2015-07 ,pp. : 596-606

John Wiley & Sons Inc

Access to resources Recommend Favorite

P169: The rate of hepatic decompensation of chronic Hepatitis C patients with advanced fibrosis after achieving sustained virological response

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 103-103

John Wiley & Sons Inc

Access to resources Recommend Favorite